From Casetext: Smarter Legal Research

HotSpot Therapeutics, Inc. v. Nurix Therapeutics, Inc.

United States District Court, Northern District of California
Feb 9, 2024
22-cv-04109-TSH (N.D. Cal. Feb. 9, 2024)

Opinion

22-cv-04109-TSH

02-09-2024

HOTSPOT THERAPEUTICS, INC., Plaintiff, v. NURIX THERAPEUTICS, INC., Defendant.


ORDER RE MOTION TO SEAL

RE: DKT. NO. 178

THOMAS S. HIXSON, UNITED STATES MAGISTRATE JUDGE

With respect to Nurix's motion at ECF No. 178, and having considered HotSpot's response at ECF No. 184, the Court ORDERS that Exhibits E, F, G, H, I, J, K and R shall remain under seal. However, sealing the entirety of Exhibits C and D is overbroad. Accordingly, HotSpot's request to seal the entirety of Exhibits C and D is DENIED WITHOUT PREJUDICE to HotSpot filing a narrowly drawn motion to seal as to those exhibits within seven days.

IT IS SO ORDERED.


Summaries of

HotSpot Therapeutics, Inc. v. Nurix Therapeutics, Inc.

United States District Court, Northern District of California
Feb 9, 2024
22-cv-04109-TSH (N.D. Cal. Feb. 9, 2024)
Case details for

HotSpot Therapeutics, Inc. v. Nurix Therapeutics, Inc.

Case Details

Full title:HOTSPOT THERAPEUTICS, INC., Plaintiff, v. NURIX THERAPEUTICS, INC.…

Court:United States District Court, Northern District of California

Date published: Feb 9, 2024

Citations

22-cv-04109-TSH (N.D. Cal. Feb. 9, 2024)